The story of Viagra, and its creator copyright, presents a challenging case study for investors. At first a blockbuster drug, producing billions in revenue , its exclusivity period created a flood of lower-priced alternatives , significantly impacting its position . While certain firms may try to capitalize on similar conditions , the existing land